Request for Covid-19 Impact Assessment of this Report
The United States Flutamide (CAS 13311-84-7) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Flutamide (CAS 13311-84-7) market, reaching US$ million by the year 2028. As for the Europe Flutamide (CAS 13311-84-7) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Flutamide (CAS 13311-84-7) players cover Forward, Merck, Tasly Diyi Pharma, and Cipla LifeScience, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Flutamide (CAS 13311-84-7) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Flutamide Tablets
Flutamide Capsule
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Forward
Merck
Tasly Diyi Pharma
Cipla LifeScience
Actiza Pharma
TEVA Pharma
Florencia Healthcare
SANDOZ
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Flutamide (CAS 13311-84-7) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Flutamide (CAS 13311-84-7) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Flutamide (CAS 13311-84-7) by Country/Region, 2017, 2022 & 2028
2.2 Flutamide (CAS 13311-84-7) Segment by Type
2.2.1 Flutamide Tablets
2.2.2 Flutamide Capsule
2.2.3 Others
2.3 Flutamide (CAS 13311-84-7) Sales by Type
2.3.1 Global Flutamide (CAS 13311-84-7) Sales Market Share by Type (2017-2022)
2.3.2 Global Flutamide (CAS 13311-84-7) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Flutamide (CAS 13311-84-7) Sale Price by Type (2017-2022)
2.4 Flutamide (CAS 13311-84-7) Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Flutamide (CAS 13311-84-7) Sales by Application
2.5.1 Global Flutamide (CAS 13311-84-7) Sale Market Share by Application (2017-2022)
2.5.2 Global Flutamide (CAS 13311-84-7) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Flutamide (CAS 13311-84-7) Sale Price by Application (2017-2022)
3 Global Flutamide (CAS 13311-84-7) by Company
3.1 Global Flutamide (CAS 13311-84-7) Breakdown Data by Company
3.1.1 Global Flutamide (CAS 13311-84-7) Annual Sales by Company (2020-2022)
3.1.2 Global Flutamide (CAS 13311-84-7) Sales Market Share by Company (2020-2022)
3.2 Global Flutamide (CAS 13311-84-7) Annual Revenue by Company (2020-2022)
3.2.1 Global Flutamide (CAS 13311-84-7) Revenue by Company (2020-2022)
3.2.2 Global Flutamide (CAS 13311-84-7) Revenue Market Share by Company (2020-2022)
3.3 Global Flutamide (CAS 13311-84-7) Sale Price by Company
3.4 Key Manufacturers Flutamide (CAS 13311-84-7) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Flutamide (CAS 13311-84-7) Product Location Distribution
3.4.2 Players Flutamide (CAS 13311-84-7) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Flutamide (CAS 13311-84-7) by Geographic Region
4.1 World Historic Flutamide (CAS 13311-84-7) Market Size by Geographic Region (2017-2022)
4.1.1 Global Flutamide (CAS 13311-84-7) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Flutamide (CAS 13311-84-7) Annual Revenue by Geographic Region
4.2 World Historic Flutamide (CAS 13311-84-7) Market Size by Country/Region (2017-2022)
4.2.1 Global Flutamide (CAS 13311-84-7) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Flutamide (CAS 13311-84-7) Annual Revenue by Country/Region
4.3 Americas Flutamide (CAS 13311-84-7) Sales Growth
4.4 APAC Flutamide (CAS 13311-84-7) Sales Growth
4.5 Europe Flutamide (CAS 13311-84-7) Sales Growth
4.6 Middle East & Africa Flutamide (CAS 13311-84-7) Sales Growth
5 Americas
5.1 Americas Flutamide (CAS 13311-84-7) Sales by Country
5.1.1 Americas Flutamide (CAS 13311-84-7) Sales by Country (2017-2022)
5.1.2 Americas Flutamide (CAS 13311-84-7) Revenue by Country (2017-2022)
5.2 Americas Flutamide (CAS 13311-84-7) Sales by Type
5.3 Americas Flutamide (CAS 13311-84-7) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Flutamide (CAS 13311-84-7) Sales by Region
6.1.1 APAC Flutamide (CAS 13311-84-7) Sales by Region (2017-2022)
6.1.2 APAC Flutamide (CAS 13311-84-7) Revenue by Region (2017-2022)
6.2 APAC Flutamide (CAS 13311-84-7) Sales by Type
6.3 APAC Flutamide (CAS 13311-84-7) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Flutamide (CAS 13311-84-7) by Country
7.1.1 Europe Flutamide (CAS 13311-84-7) Sales by Country (2017-2022)
7.1.2 Europe Flutamide (CAS 13311-84-7) Revenue by Country (2017-2022)
7.2 Europe Flutamide (CAS 13311-84-7) Sales by Type
7.3 Europe Flutamide (CAS 13311-84-7) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Flutamide (CAS 13311-84-7) by Country
8.1.1 Middle East & Africa Flutamide (CAS 13311-84-7) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Flutamide (CAS 13311-84-7) Revenue by Country (2017-2022)
8.2 Middle East & Africa Flutamide (CAS 13311-84-7) Sales by Type
8.3 Middle East & Africa Flutamide (CAS 13311-84-7) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Flutamide (CAS 13311-84-7)
10.3 Manufacturing Process Analysis of Flutamide (CAS 13311-84-7)
10.4 Industry Chain Structure of Flutamide (CAS 13311-84-7)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Flutamide (CAS 13311-84-7) Distributors
11.3 Flutamide (CAS 13311-84-7) Customer
12 World Forecast Review for Flutamide (CAS 13311-84-7) by Geographic Region
12.1 Global Flutamide (CAS 13311-84-7) Market Size Forecast by Region
12.1.1 Global Flutamide (CAS 13311-84-7) Forecast by Region (2023-2028)
12.1.2 Global Flutamide (CAS 13311-84-7) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Flutamide (CAS 13311-84-7) Forecast by Type
12.7 Global Flutamide (CAS 13311-84-7) Forecast by Application
13 Key Players Analysis
13.1 Forward
13.1.1 Forward Company Information
13.1.2 Forward Flutamide (CAS 13311-84-7) Product Offered
13.1.3 Forward Flutamide (CAS 13311-84-7) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Forward Main Business Overview
13.1.5 Forward Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Flutamide (CAS 13311-84-7) Product Offered
13.2.3 Merck Flutamide (CAS 13311-84-7) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Tasly Diyi Pharma
13.3.1 Tasly Diyi Pharma Company Information
13.3.2 Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Product Offered
13.3.3 Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Tasly Diyi Pharma Main Business Overview
13.3.5 Tasly Diyi Pharma Latest Developments
13.4 Cipla LifeScience
13.4.1 Cipla LifeScience Company Information
13.4.2 Cipla LifeScience Flutamide (CAS 13311-84-7) Product Offered
13.4.3 Cipla LifeScience Flutamide (CAS 13311-84-7) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Cipla LifeScience Main Business Overview
13.4.5 Cipla LifeScience Latest Developments
13.5 Actiza Pharma
13.5.1 Actiza Pharma Company Information
13.5.2 Actiza Pharma Flutamide (CAS 13311-84-7) Product Offered
13.5.3 Actiza Pharma Flutamide (CAS 13311-84-7) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Actiza Pharma Main Business Overview
13.5.5 Actiza Pharma Latest Developments
13.6 TEVA Pharma
13.6.1 TEVA Pharma Company Information
13.6.2 TEVA Pharma Flutamide (CAS 13311-84-7) Product Offered
13.6.3 TEVA Pharma Flutamide (CAS 13311-84-7) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 TEVA Pharma Main Business Overview
13.6.5 TEVA Pharma Latest Developments
13.7 Florencia Healthcare
13.7.1 Florencia Healthcare Company Information
13.7.2 Florencia Healthcare Flutamide (CAS 13311-84-7) Product Offered
13.7.3 Florencia Healthcare Flutamide (CAS 13311-84-7) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Florencia Healthcare Main Business Overview
13.7.5 Florencia Healthcare Latest Developments
13.8 SANDOZ
13.8.1 SANDOZ Company Information
13.8.2 SANDOZ Flutamide (CAS 13311-84-7) Product Offered
13.8.3 SANDOZ Flutamide (CAS 13311-84-7) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 SANDOZ Main Business Overview
13.8.5 SANDOZ Latest Developments
14 Research Findings and Conclusion
Table 1. Flutamide (CAS 13311-84-7) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Flutamide (CAS 13311-84-7) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Flutamide Tablets
Table 4. Major Players of Flutamide Capsule
Table 5. Major Players of Others
Table 6. Global Flutamide (CAS 13311-84-7) Sales by Type (2017-2022) & (Kg)
Table 7. Global Flutamide (CAS 13311-84-7) Sales Market Share by Type (2017-2022)
Table 8. Global Flutamide (CAS 13311-84-7) Revenue by Type (2017-2022) & ($ million)
Table 9. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Type (2017-2022)
Table 10. Global Flutamide (CAS 13311-84-7) Sale Price by Type (2017-2022) & (USD/Kg)
Table 11. Global Flutamide (CAS 13311-84-7) Sales by Application (2017-2022) & (Kg)
Table 12. Global Flutamide (CAS 13311-84-7) Sales Market Share by Application (2017-2022)
Table 13. Global Flutamide (CAS 13311-84-7) Revenue by Application (2017-2022)
Table 14. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Application (2017-2022)
Table 15. Global Flutamide (CAS 13311-84-7) Sale Price by Application (2017-2022) & (USD/Kg)
Table 16. Global Flutamide (CAS 13311-84-7) Sales by Company (2020-2022) & (Kg)
Table 17. Global Flutamide (CAS 13311-84-7) Sales Market Share by Company (2020-2022)
Table 18. Global Flutamide (CAS 13311-84-7) Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Company (2020-2022)
Table 20. Global Flutamide (CAS 13311-84-7) Sale Price by Company (2020-2022) & (USD/Kg)
Table 21. Key Manufacturers Flutamide (CAS 13311-84-7) Producing Area Distribution and Sales Area
Table 22. Players Flutamide (CAS 13311-84-7) Products Offered
Table 23. Flutamide (CAS 13311-84-7) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Flutamide (CAS 13311-84-7) Sales by Geographic Region (2017-2022) & (Kg)
Table 27. Global Flutamide (CAS 13311-84-7) Sales Market Share Geographic Region (2017-2022)
Table 28. Global Flutamide (CAS 13311-84-7) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Flutamide (CAS 13311-84-7) Sales by Country/Region (2017-2022) & (Kg)
Table 31. Global Flutamide (CAS 13311-84-7) Sales Market Share by Country/Region (2017-2022)
Table 32. Global Flutamide (CAS 13311-84-7) Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Flutamide (CAS 13311-84-7) Sales by Country (2017-2022) & (Kg)
Table 35. Americas Flutamide (CAS 13311-84-7) Sales Market Share by Country (2017-2022)
Table 36. Americas Flutamide (CAS 13311-84-7) Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Flutamide (CAS 13311-84-7) Revenue Market Share by Country (2017-2022)
Table 38. Americas Flutamide (CAS 13311-84-7) Sales by Type (2017-2022) & (Kg)
Table 39. Americas Flutamide (CAS 13311-84-7) Sales Market Share by Type (2017-2022)
Table 40. Americas Flutamide (CAS 13311-84-7) Sales by Application (2017-2022) & (Kg)
Table 41. Americas Flutamide (CAS 13311-84-7) Sales Market Share by Application (2017-2022)
Table 42. APAC Flutamide (CAS 13311-84-7) Sales by Region (2017-2022) & (Kg)
Table 43. APAC Flutamide (CAS 13311-84-7) Sales Market Share by Region (2017-2022)
Table 44. APAC Flutamide (CAS 13311-84-7) Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Flutamide (CAS 13311-84-7) Revenue Market Share by Region (2017-2022)
Table 46. APAC Flutamide (CAS 13311-84-7) Sales by Type (2017-2022) & (Kg)
Table 47. APAC Flutamide (CAS 13311-84-7) Sales Market Share by Type (2017-2022)
Table 48. APAC Flutamide (CAS 13311-84-7) Sales by Application (2017-2022) & (Kg)
Table 49. APAC Flutamide (CAS 13311-84-7) Sales Market Share by Application (2017-2022)
Table 50. Europe Flutamide (CAS 13311-84-7) Sales by Country (2017-2022) & (Kg)
Table 51. Europe Flutamide (CAS 13311-84-7) Sales Market Share by Country (2017-2022)
Table 52. Europe Flutamide (CAS 13311-84-7) Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Flutamide (CAS 13311-84-7) Revenue Market Share by Country (2017-2022)
Table 54. Europe Flutamide (CAS 13311-84-7) Sales by Type (2017-2022) & (Kg)
Table 55. Europe Flutamide (CAS 13311-84-7) Sales Market Share by Type (2017-2022)
Table 56. Europe Flutamide (CAS 13311-84-7) Sales by Application (2017-2022) & (Kg)
Table 57. Europe Flutamide (CAS 13311-84-7) Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Flutamide (CAS 13311-84-7) Sales by Country (2017-2022) & (Kg)
Table 59. Middle East & Africa Flutamide (CAS 13311-84-7) Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Flutamide (CAS 13311-84-7) Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Flutamide (CAS 13311-84-7) Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Flutamide (CAS 13311-84-7) Sales by Type (2017-2022) & (Kg)
Table 63. Middle East & Africa Flutamide (CAS 13311-84-7) Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Flutamide (CAS 13311-84-7) Sales by Application (2017-2022) & (Kg)
Table 65. Middle East & Africa Flutamide (CAS 13311-84-7) Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Flutamide (CAS 13311-84-7)
Table 67. Key Market Challenges & Risks of Flutamide (CAS 13311-84-7)
Table 68. Key Industry Trends of Flutamide (CAS 13311-84-7)
Table 69. Flutamide (CAS 13311-84-7) Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Flutamide (CAS 13311-84-7) Distributors List
Table 72. Flutamide (CAS 13311-84-7) Customer List
Table 73. Global Flutamide (CAS 13311-84-7) Sales Forecast by Region (2023-2028) & (Kg)
Table 74. Global Flutamide (CAS 13311-84-7) Sales Market Forecast by Region
Table 75. Global Flutamide (CAS 13311-84-7) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Flutamide (CAS 13311-84-7) Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Flutamide (CAS 13311-84-7) Sales Forecast by Country (2023-2028) & (Kg)
Table 78. Americas Flutamide (CAS 13311-84-7) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Flutamide (CAS 13311-84-7) Sales Forecast by Region (2023-2028) & (Kg)
Table 80. APAC Flutamide (CAS 13311-84-7) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Flutamide (CAS 13311-84-7) Sales Forecast by Country (2023-2028) & (Kg)
Table 82. Europe Flutamide (CAS 13311-84-7) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Flutamide (CAS 13311-84-7) Sales Forecast by Country (2023-2028) & (Kg)
Table 84. Middle East & Africa Flutamide (CAS 13311-84-7) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Flutamide (CAS 13311-84-7) Sales Forecast by Type (2023-2028) & (Kg)
Table 86. Global Flutamide (CAS 13311-84-7) Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Flutamide (CAS 13311-84-7) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Flutamide (CAS 13311-84-7) Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Flutamide (CAS 13311-84-7) Sales Forecast by Application (2023-2028) & (Kg)
Table 90. Global Flutamide (CAS 13311-84-7) Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Flutamide (CAS 13311-84-7) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Flutamide (CAS 13311-84-7) Revenue Market Share Forecast by Application (2023-2028)
Table 93. Forward Basic Information, Flutamide (CAS 13311-84-7) Manufacturing Base, Sales Area and Its Competitors
Table 94. Forward Flutamide (CAS 13311-84-7) Product Offered
Table 95. Forward Flutamide (CAS 13311-84-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 96. Forward Main Business
Table 97. Forward Latest Developments
Table 98. Merck Basic Information, Flutamide (CAS 13311-84-7) Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck Flutamide (CAS 13311-84-7) Product Offered
Table 100. Merck Flutamide (CAS 13311-84-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 101. Merck Main Business
Table 102. Merck Latest Developments
Table 103. Tasly Diyi Pharma Basic Information, Flutamide (CAS 13311-84-7) Manufacturing Base, Sales Area and Its Competitors
Table 104. Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Product Offered
Table 105. Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 106. Tasly Diyi Pharma Main Business
Table 107. Tasly Diyi Pharma Latest Developments
Table 108. Cipla LifeScience Basic Information, Flutamide (CAS 13311-84-7) Manufacturing Base, Sales Area and Its Competitors
Table 109. Cipla LifeScience Flutamide (CAS 13311-84-7) Product Offered
Table 110. Cipla LifeScience Flutamide (CAS 13311-84-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 111. Cipla LifeScience Main Business
Table 112. Cipla LifeScience Latest Developments
Table 113. Actiza Pharma Basic Information, Flutamide (CAS 13311-84-7) Manufacturing Base, Sales Area and Its Competitors
Table 114. Actiza Pharma Flutamide (CAS 13311-84-7) Product Offered
Table 115. Actiza Pharma Flutamide (CAS 13311-84-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 116. Actiza Pharma Main Business
Table 117. Actiza Pharma Latest Developments
Table 118. TEVA Pharma Basic Information, Flutamide (CAS 13311-84-7) Manufacturing Base, Sales Area and Its Competitors
Table 119. TEVA Pharma Flutamide (CAS 13311-84-7) Product Offered
Table 120. TEVA Pharma Flutamide (CAS 13311-84-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 121. TEVA Pharma Main Business
Table 122. TEVA Pharma Latest Developments
Table 123. Florencia Healthcare Basic Information, Flutamide (CAS 13311-84-7) Manufacturing Base, Sales Area and Its Competitors
Table 124. Florencia Healthcare Flutamide (CAS 13311-84-7) Product Offered
Table 125. Florencia Healthcare Flutamide (CAS 13311-84-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 126. Florencia Healthcare Main Business
Table 127. Florencia Healthcare Latest Developments
Table 128. SANDOZ Basic Information, Flutamide (CAS 13311-84-7) Manufacturing Base, Sales Area and Its Competitors
Table 129. SANDOZ Flutamide (CAS 13311-84-7) Product Offered
Table 130. SANDOZ Flutamide (CAS 13311-84-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 131. SANDOZ Main Business
Table 132. SANDOZ Latest Developments
List of Figures
Figure 1. Picture of Flutamide (CAS 13311-84-7)
Figure 2. Flutamide (CAS 13311-84-7) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Flutamide (CAS 13311-84-7) Sales Growth Rate 2017-2028 (Kg)
Figure 7. Global Flutamide (CAS 13311-84-7) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Flutamide (CAS 13311-84-7) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Flutamide Tablets
Figure 10. Product Picture of Flutamide Capsule
Figure 11. Product Picture of Others
Figure 12. Global Flutamide (CAS 13311-84-7) Sales Market Share by Type in 2021
Figure 13. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Type (2017-2022)
Figure 14. Flutamide (CAS 13311-84-7) Consumed in Hospital Pharmacies
Figure 15. Global Flutamide (CAS 13311-84-7) Market: Hospital Pharmacies (2017-2022) & (Kg)
Figure 16. Flutamide (CAS 13311-84-7) Consumed in Retail Pharmacies
Figure 17. Global Flutamide (CAS 13311-84-7) Market: Retail Pharmacies (2017-2022) & (Kg)
Figure 18. Flutamide (CAS 13311-84-7) Consumed in Online Pharmacies
Figure 19. Global Flutamide (CAS 13311-84-7) Market: Online Pharmacies (2017-2022) & (Kg)
Figure 20. Global Flutamide (CAS 13311-84-7) Sales Market Share by Application (2017-2022)
Figure 21. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Application in 2021
Figure 22. Flutamide (CAS 13311-84-7) Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Company in 2021
Figure 24. Global Flutamide (CAS 13311-84-7) Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Geographic Region in 2021
Figure 26. Global Flutamide (CAS 13311-84-7) Sales Market Share by Region (2017-2022)
Figure 27. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Country/Region in 2021
Figure 28. Americas Flutamide (CAS 13311-84-7) Sales 2017-2022 (Kg)
Figure 29. Americas Flutamide (CAS 13311-84-7) Revenue 2017-2022 ($ Millions)
Figure 30. APAC Flutamide (CAS 13311-84-7) Sales 2017-2022 (Kg)
Figure 31. APAC Flutamide (CAS 13311-84-7) Revenue 2017-2022 ($ Millions)
Figure 32. Europe Flutamide (CAS 13311-84-7) Sales 2017-2022 (Kg)
Figure 33. Europe Flutamide (CAS 13311-84-7) Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Flutamide (CAS 13311-84-7) Sales 2017-2022 (Kg)
Figure 35. Middle East & Africa Flutamide (CAS 13311-84-7) Revenue 2017-2022 ($ Millions)
Figure 36. Americas Flutamide (CAS 13311-84-7) Sales Market Share by Country in 2021
Figure 37. Americas Flutamide (CAS 13311-84-7) Revenue Market Share by Country in 2021
Figure 38. United States Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Flutamide (CAS 13311-84-7) Sales Market Share by Region in 2021
Figure 43. APAC Flutamide (CAS 13311-84-7) Revenue Market Share by Regions in 2021
Figure 44. China Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Flutamide (CAS 13311-84-7) Sales Market Share by Country in 2021
Figure 51. Europe Flutamide (CAS 13311-84-7) Revenue Market Share by Country in 2021
Figure 52. Germany Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Flutamide (CAS 13311-84-7) Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Flutamide (CAS 13311-84-7) Revenue Market Share by Country in 2021
Figure 59. Egypt Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Flutamide (CAS 13311-84-7) in 2021
Figure 65. Manufacturing Process Analysis of Flutamide (CAS 13311-84-7)
Figure 66. Industry Chain Structure of Flutamide (CAS 13311-84-7)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...